CA2306818A1 - Millepertuis de qualite pharmaceutique - Google Patents

Millepertuis de qualite pharmaceutique Download PDF

Info

Publication number
CA2306818A1
CA2306818A1 CA002306818A CA2306818A CA2306818A1 CA 2306818 A1 CA2306818 A1 CA 2306818A1 CA 002306818 A CA002306818 A CA 002306818A CA 2306818 A CA2306818 A CA 2306818A CA 2306818 A1 CA2306818 A1 CA 2306818A1
Authority
CA
Canada
Prior art keywords
john
wort
pharmaceutical grade
bioactivity
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002306818A
Other languages
English (en)
Inventor
Elliot P. Friedman
Tasneem A. Khwaja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaPrint Inc
University of Southern California USC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/956,602 external-priority patent/US6113907A/en
Application filed by Individual filed Critical Individual
Publication of CA2306818A1 publication Critical patent/CA2306818A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention a trait de manière générale à des matières de ginseng et à des procédés de transformation de ces matières en formes utiles d'un point de vue médicinal et pharmaceutiquement acceptables. Plus particulièrement, l'invention a trait à l'utilisation d'empreintes de composition et d'activité dans le traitement de matières de ginseng pour produire des médicaments qui remplissent les conditions requises pour constituer des compositions de qualité pharmaceutique convenant pour un usage clinique ou vétérinaire en vue de traiter et/ou soulager des maladies, des affections ou des états pathologiques.
CA002306818A 1997-10-23 1998-10-23 Millepertuis de qualite pharmaceutique Abandoned CA2306818A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/956,602 US6113907A (en) 1997-04-15 1997-10-23 Pharmaceutical grade St. John's Wort
US08/956,602 1997-10-23
US15931398A 1998-09-23 1998-09-23
US09/159,313 1998-09-23
PCT/US1998/022504 WO1999021005A2 (fr) 1997-10-23 1998-10-23 Millepertuis de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
CA2306818A1 true CA2306818A1 (fr) 1999-04-29

Family

ID=26855832

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306818A Abandoned CA2306818A1 (fr) 1997-10-23 1998-10-23 Millepertuis de qualite pharmaceutique

Country Status (4)

Country Link
EP (1) EP1094825A2 (fr)
AU (1) AU1363199A (fr)
CA (1) CA2306818A1 (fr)
WO (1) WO1999021005A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100407399B1 (ko) * 2000-08-22 2003-11-28 주식회사 뉴로넥스 세로토닌 n-아세틸트란스퍼라제의 활성 억제제
BR0204228A (pt) * 2001-02-20 2004-06-22 Randy Ziegler Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânico
CN111175428B (zh) * 2020-01-07 2022-09-09 江苏省中医院 补肾助孕颗粒指纹图谱的检测方法
CN112697899B (zh) * 2020-12-07 2022-04-12 中国药科大学 一种银杏黄酮醇苷的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH680570A5 (en) * 1990-10-30 1992-09-30 Flint Ag Allergen-free St. Johns wort extract prodn. to prevent skin tumour - by macerating mechanically comminuted St. Johns wort and camomile with a plant oil e.g. wheat germ, thistle, sunflower seed, etc.
US6379714B1 (en) * 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs

Also Published As

Publication number Publication date
AU1363199A (en) 1999-05-10
WO1999021005A3 (fr) 2001-02-22
WO1999021005A2 (fr) 1999-04-29
EP1094825A2 (fr) 2001-05-02

Similar Documents

Publication Publication Date Title
US6113907A (en) Pharmaceutical grade St. John's Wort
AU716155B2 (en) Pharmaceutical grade botanical drugs
US6039950A (en) Pharmaceutical grade saw palmetto
Zakaria et al. LCMS/MS Metabolite Profling and Analysis of Acute Toxicity Effect of the Ethanolic Extract of Centella asiatica on Zebrafsh Model.
Mutreja et al. Effect of Nelumbo nucifera seeds on the reproductive organs of female rats
AU1363499A (en) Pharmaceutical grade echinacea
Arwati et al. The effect of dayak onion bulb-stem (Eleutherine palmifolia (l.,) Merr.) extract on blood glucose levels of mouse suffered diabetes mellitus
Karamcheti et al. Chemoprotective effect of ethanolic extract of Morinda citrifolia against Cisplatin induced nephrotoxicity
Rohmah et al. Antioxidant activity assay of white Turi (Sesbania grandiflora (L.) Pers.) extracts using DPPH radical scavenging method
CA2306818A1 (fr) Millepertuis de qualite pharmaceutique
WO1999020291A2 (fr) Gingko biloba de qualite pharmaceutique
WO1999021006A9 (fr) Valeriane, actee a grappes, vitex agnus-castus, airelle et chardon-marie de qualite pharmaceutique
WO1999020292A1 (fr) Ginseng de qualite pharmaceutique
CA2306812A1 (fr) Ail de qualite pharmaceutique
kumar Agrahari et al. Phytochemical screening of Curculigo orchioides Gaertn. root tubers
Shrivastava et al. Extensive review on the analytical methods for the estimation of Thuja occidentalis homeopathic mother tincture
Uzor et al. Antidiabetic Studies and Dereplication of the Bioactive Constituents of Anthocleista nobilis G. Don by UHPLC/ESI-QTOF-MS
Mathew et al. Study of in vitro antiinflammatory and immunomodulatory effect of Ayurvedic plants–Murva
Kotsupiy et al. Phenolic Compounds in Leaves and Inflorescences of Hedysarum alpinum L. and H. flavescens Regel et Schmalh., Introduced into the Forest-Steppe Zone of Western Siberia
CN103739611A (zh) 一种中药药物原料的制备方法及其制剂
Sarada et al. Qualitative and quantitative estimation of chemical constituents in Naringi crenulata (Roxb.) Nicolson.
Mondal et al. EVALUATION OF DIURETIC AND LAXATIVE ACTIVITIES OF ETHANOL EXTRACT FROM IXORA PAVETTA LEAF
Wijatmadi et al. The Effect of Dayak Onion Bulb-Stem (Eleutherine Palmifolia (L.,) Merr.) Extract on Blood Glucose Levels of Mouse Suffered Diabetes Mellitus
CN103739612A (zh) 一种中药药物原料

Legal Events

Date Code Title Description
FZDE Discontinued